Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $108 million in its fourth quarter.
CAMBRIDGE, Mass.(AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $108 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.85 per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.97 per share.
The biopharmaceutical company posted revenue of $20 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $10.3 million.
For the year, the company reported a loss of $412.8 million, or $7.12 per share, swinging to a loss in the period. Revenue was reported as $54 million.
Agios Pharmaceuticals shares have climbed nearly 2% since the beginning of the year. The stock has dropped 15% in the last 12 months.
This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on AGIO at
Copyright 2025 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
date: 2026-02-12 11:50:00